Day: July 12, 2019

AGILeBiotics has received the Lead Development Voucher from the Netherlands Antibiotic Development Platform

We are proud to announce that AGILeBiotics has been awarded the Lead Development Voucher by the Netherlands Antibiotic Development Platform (NADP). The total amount of €50.000 will be allocated to the pre-clinical R&D activities. With this financial support we will evaluate the in vivo efficacy of our antibiotic candidates in a clinically relevant animal model […]